The known antioxidant edaravone could effectively attenuate cognitive impairment; its protective mechanism may be related to its antioxidant and anti-inflammatory effects, as well as its ability to maintain activation of the Akt/mTOR signaling pathway. This evidence concerns the gene AKT1 and Cognitive impairment.